Page last updated: 2024-08-17

nad and Autoimmune Disease

nad has been researched along with Autoimmune Disease in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19903 (27.27)18.7374
1990's2 (18.18)18.2507
2000's3 (27.27)29.6817
2010's2 (18.18)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
Bogaczewicz, J; Tokarska, K; Wozniacka, A1
Almaliki, MS; Omran, HM1
Chang, C; Long, H; Lu, Q; Wang, Z; Zhao, M1
Penberthy, WT1
Forouhar, F; Khan, JA; Tao, X; Tong, L1
Aelbrecht, W; Gorus, F; Van Camp, B1
Cockle, S; Robbinson, D; Singh, B; Strejan, GH1
Gilson, G; Humbel, RL; Schmit, P1
Nimmesgern, E; Sintchak, MD1
Atlef, N; Doll, N; Hermitte, L; Payan, MJ; Scheimann, A; Vague, P; Vialettes, B1
Aruin, LI1

Reviews

6 review(s) available for nad and Autoimmune Disease

ArticleYear
Influence of NAD+ as an ageing-related immunomodulator on COVID 19 infection: A hypothesis.
    Journal of infection and public health, 2020, Volume: 13, Issue:9

    Topics: Aging; Autoimmune Diseases; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokines; Humans; NAD; Pandemics; Pneumonia, Viral; Poly (ADP-Ribose) Polymerase-1; SARS-CoV-2; Telomere Shortening

2020
Crosstalk between metabolism and epigenetic modifications in autoimmune diseases: a comprehensive overview.
    Cellular and molecular life sciences : CMLS, 2018, Volume: 75, Issue:18

    Topics: Acetyl Coenzyme A; Autoimmune Diseases; Chromatin; Epigenomics; Histones; Humans; Methylation; NAD; S-Adenosylmethionine; Sirtuins

2018
Pharmacological targeting of IDO-mediated tolerance for treating autoimmune disease.
    Current drug metabolism, 2007, Volume: 8, Issue:3

    Topics: Animals; Autoimmune Diseases; Humans; Immune Tolerance; Indoleamine-Pyrrole 2,3,-Dioxygenase; NAD; Niacin; Niacinamide

2007
Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery.
    Expert opinion on therapeutic targets, 2007, Volume: 11, Issue:5

    Topics: Acrylamides; Adenosine Diphosphate Ribose; Aging; Animals; Antineoplastic Agents; Autoimmune Diseases; Clinical Trials, Phase II as Topic; Cyclic ADP-Ribose; DNA Damage; Drug Design; Enzyme Inhibitors; Humans; Kynurenine; Mice; NAD; Neoplasms; Neurodegenerative Diseases; Neuroprotective Agents; Piperidines; Poly Adenosine Diphosphate Ribose; Signal Transduction; Sirtuins; Tryptophan

2007
The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors.
    Immunopharmacology, 2000, Volume: 47, Issue:2-3

    Topics: Animals; Autoimmune Diseases; Drug Design; Enzyme Inhibitors; Guanine Nucleotides; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Mycophenolic Acid; NAD

2000
[Morphologic study of biopsies of the gastric mucosa].
    Arkhiv patologii, 1969, Volume: 31, Issue:3

    Topics: Acid Phosphatase; Adenosine Triphosphatases; Alkaline Phosphatase; Autoimmune Diseases; Autoradiography; Biopsy; Chronic Disease; Gastric Juice; Gastric Mucosa; Gastritis; Glycosaminoglycans; Histocytochemistry; Humans; Microscopy, Electron; Mitosis; NAD; NADP; Oxidoreductases; Pyrophosphatases; RNA

1969

Other Studies

5 other study(ies) available for nad and Autoimmune Disease

ArticleYear
Changes of NADH Fluorescence from the Skin of Patients with Systemic Lupus Erythematosus.
    BioMed research international, 2019, Volume: 2019

    Topics: Adult; Aged; Aged, 80 and over; Arthritis; Autoimmune Diseases; Case-Control Studies; Female; Fluorescence; Humans; Lupus Erythematosus, Systemic; Male; Microcirculation; Middle Aged; NAD; Skin; Young Adult

2019
Circulating IgG-LD complex, dissociable by addition of NAD+.
    Clinical chemistry, 1982, Volume: 28, Issue:1

    Topics: Aged; Autoimmune Diseases; Binding, Competitive; Chromatography, Gel; Humans; Immunoglobulin G; Isoenzymes; Kinetics; L-Lactate Dehydrogenase; Male; NAD; Protein Binding; Pulmonary Fibrosis

1982
Native, but not genetically inactivated, pertussis toxin protects mice against experimental allergic encephalomyelitis.
    Cellular immunology, 1996, Mar-15, Volume: 168, Issue:2

    Topics: Allosteric Site; Amino Acid Sequence; Animals; Autoimmune Diseases; Binding Sites; Encephalomyelitis, Autoimmune, Experimental; Female; Freund's Adjuvant; Immunosuppressive Agents; Immunotherapy, Adoptive; Ionophores; Lymph Nodes; Lymphocyte Activation; Mice; Mice, Inbred Strains; Mitogens; Molecular Sequence Data; Muromonab-CD3; Mutagenesis, Site-Directed; Myelin Proteins; Myelin Proteolipid Protein; NAD; Peptide Fragments; Pertussis Toxin; Poly(ADP-ribose) Polymerases; Signal Transduction; Tuberculin; Virulence Factors, Bordetella

1996
Evaluation of an automated enzyme inhibition assay for the detection of anti-mitochondrial M2 autoantibodies.
    Clinical chemistry, 1999, Volume: 45, Issue:12

    Topics: Autoantibodies; Autoimmune Diseases; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Humans; Liver Cirrhosis, Biliary; Mitochondria; NAD; Pyruvate Dehydrogenase Complex; Reagent Kits, Diagnostic; Sensitivity and Specificity; Spectrophotometry, Ultraviolet

1999
High dose nicotinamide fails to prevent diabetes in BB rats.
    Autoimmunity, 1989, Volume: 5, Issue:1-2

    Topics: Age Factors; Animals; Autoimmune Diseases; Blood Glucose; Cyclosporine; Deferoxamine; Diabetes Mellitus, Experimental; DNA Damage; Drug Evaluation, Preclinical; Hyperplasia; Insulin; Insulin Secretion; Islets of Langerhans; Models, Biological; NAD; Niacinamide; Poly(ADP-ribose) Polymerase Inhibitors; Rats; Rats, Inbred BB

1989
chemdatabank.com